The Note SP holds in TuHURA Biosciences was converted as the result of a merger of the company with Kintara Therapeutics (KTRA). The note converted into 31,571 common shares of the combined companies following a concurrent reverse stock split. The combined companies are trading under the name TuHURA Biosciences, trading symbol HURA.
